growth factors

Growth factor is sometimes used interchangeably among scientists with the term cytokine. Historically, cytokines were associated with hematopoietic (blood forming) cells and immune system cells (e.g., lymphocytes and tissue cells from spleen, thymus, and lymph nodes). For the circulatory system and bone marrow in which cells can occur in a liquid suspension and not bound up in solid tissue, it makes sense for them to communicate by soluble, circulating protein molecules. However, as different lines of research converged, it became clear that some of the same signaling proteins the hematopoietic and immune systems used were also being used by all sorts of other cells and tissues, during development and in the mature organism.
While growth factor implies a positive effect on cell division, cytokine is a neutral term with respect to whether a molecule affects proliferation. In this sense, some cytokines can be growth factors, such as G-CSF and GM-CSF. However, some cytokines have an inhibitory effect on cell growth or proliferation. Yet others, such as Fas ligand are used as "death" signals; they cause target cells to undergo programmed cell death or apoptosis.

Example of growth factors
Individual growth factor proteins tend to occur as members of larger families of structurally and evolutionarily related proteins. There are dozens and dozens of growth factor families such as TGF-beta (transforming growth factor-beta), BMP (bone morphogenic protein), neurotrophins (NGF, BDNF, and NT3), fibroblast growth factor (FGF), and so on.
Several well known growth factors are:
1Transforming growth factor beta (TGF-β)
2Granulocyte-colony stimulating factor (G-CSF)
3Granulocyte-macrophage colony stimulating factor (GM-CSF)
4Nerve growth factor (NGF)
5Neurotrophins
6Platelet-derived growth factor (PDGF)
7Erythropoietin (EPO)
8Thrombopoietin (TPO)
9Myostatin (GDF-8)
10Growth differentiation factor-9 (GDF9)
11Acidic fibroblast growth factor (aFGF or FGF-1)
12Basic fibroblast growth factor (bFGF or FGF-2)
13Epidermal growth factor (EGF)
14Hepatocyte growth factor (HGF)

.

vaccine

A vaccine is a biological preparation which is used to establish or improve immunity to a particular disease.

Vaccines can be prophylactic (e.g. to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g. vaccines against cancer are also being investigated; see cancer vaccine).

The term "vaccine" derives from Edward Jenner's 1796 use of cowpox (Latin variolæ vaccinæ, adapted from the Latin vaccīn-us, from vacca cow), which, when administered to humans, provided them protection against smallpox.

History

The earliest vaccines were based on the concept of variolation originating in China, in which a person is deliberately infected with a weak form of smallpox as a form of inoculation. Jenner realized that milkmaids who had contact with cowpox did not get smallpox. The process of distributing and administrating vaccines is thus referred to as "vaccination". Jenner's work was continued by Louis Pasteur and others in the 19th century. Since vaccination against smallpox was much safer than smallpox inoculation, the latter fell into disuse and was eventually banned in England in 1849.

The 19th and 20th centuries saw the introduction of several successful vaccines against a number of infectious diseases. These included bacterial and viral diseases, but not (to date) any parasitic diseases.

Types

Avian Flu vaccine development by reverse genetics techniques.

Vaccines may be dead or inactivated organisms or purified products derived from them.

There are four types of traditional vaccines:^[1]

• Vaccines containing killed microorganisms - these are previously virulent micro-organisms which have been killed with chemicals or heat. Examples are vaccines against flu, cholera, bubonic plague, and hepatitis A.
• Vaccines containing live, attenuated virus microorganisms - these are live micro-organisms that have been cultivated under conditions that disable their virulent properties or which use closely-related but less dangerous organisms to produce a broad immune response. They typically provoke more durable immunological responses and are the preferred type for healthy adults. Examples include yellow fever, measles, rubella, and mumps. The live tuberculosis vaccine is not the contagious strain, but a related strain called "BCG"; it is used in the United States very infrequently.
• Toxoids - these are inactivated toxic compounds in cases where these (rather than the micro-organism itself) cause illness. Examples of toxoid-based vaccines include tetanus and diphtheria. Not all toxoids are for micro-organisms; for example, Crotalis atrox toxoid is used to vaccinate dogs against rattlesnake bites.
• Subunit - rather than introducing an inactivated or attenuated micro-organism to an immune system (which would constitute a "whole-agent" vaccine), a fragment of it can create an immune response. Characteristic examples include the subunit vaccine against HBV that is composed of only the surface proteins of the virus (produced in yeast) and the virus-like particle (VLP) vaccine against human papillomavirus (HPV) that is composed of the viral major capsid protein.

A number of innovative vaccines are also in development and in use:

• Conjugate - certain bacteria have polysaccharide outer coats that are poorly immunogenic. By linking these outer coats to proteins (e.g. toxins), the immune system can be led to recognize the polysaccharide as if it were a protein antigen. This approach is used in the Haemophilus influenzae type B vaccine.
• Recombinant Vector - by combining the physiology of one micro-organism and the DNA of the other, immunity can be created against diseases that have complex infection processes
• DNA vaccination - in recent years a new type of vaccine, created from an infectious agent's DNA called DNA vaccination, has been developed. It works by insertion (and expression, triggering immune system recognition) into human or animal cells, of viral or bacterial DNA. Some cells of the immune system that recognize the proteins expressed will mount an attack against these proteins and cells expressing them. Because these cells live for a very long time, if the pathogen that normally expresses these proteins is encountered at a later time, they will be attacked instantly by the immune system. One advantage of DNA vaccines is that they are very easy to produce and store. As of 2006, DNA vaccination is still experimental.

While most vaccines are created using inactivated or attenuated compounds from micro-organisms, synthetic vaccines are composed mainly or wholly of synthetic peptides, carbohydrates or antigens.

Vaccines may be monovalent (also called univalent) or multivalent (also called polyvalent). A monovalent vaccine is designed to immunize against a single antigen or single microorganism.^[2] A multivalent or polyvalent vaccine is designed to immunize against two or more strains of the same microorganism, or against two or more microorganisms.^[3]

ORYZA

Scientific classification
Kingdom:Plantae
(unranked):Angiosperms
(unranked):Monocots
(unranked):Commelinids
Order:Poales
Family:Poaceae
Subfamily:Bambusoideae
Tribe:Oryzeae
Genus:OryzaL.

Oryza is a genus of 7-20 species of grasses in the tribe Oryzeae, within the subfamily Bambusoideae. native to tropical and subtropical regions of Asia and Africa. They are tall wetland grasses, growing to 1-2 m tall; the genus includes both annual and perennial species.
Oryza is situated within the tribe Oryzeae, which is characterized morphologically by its single flowered spikelets whose glumes are almost completely suppressed. In Oryza, two sterile lemma simulate glumes. The tribe Oryzeae is within the subfamily Bambusoideae, a group of Poaceae tribes with certain features of internal leaf anatomy in common. The most distinctive leaf character of this subfamily is their arm cells and fusoid cells found in their leafs. The Bambusoideae are in the family Poaceae, as they all have fibrous root systems, cylindrical stems, sheathing leaves with parallel veined blades, and inflorescences with spikelets. [1]
While USDA plants lists only 7 species, others have identified up to 17, including sativa, barthii, glaberrima, meridionalis, nivara, rufipogon, punctata, latifolia, alta, grandiglumis, eichingeri, officinalis, rhisomatis, minuta, australiensis, granulata, meyeriana, and brachyantha. One species, Rice (O. sativa), provides twenty percent of global grain and is a food crop of major global importance. The many species mentioned above are divided into two subgroups within the genus
Selected species
Oryza barthii
Oryza glaberrima
Oryza latifolia
Oryza longistaminata
Oryza punctata
Oryza rufipogon
Oryza sativa